Zero-knowledge proofs of geospatial provenance assertions (e.g. "this record originated within 10 km of a named clinical trial site") can be integrated with federated transcriptomic datasets to enable privacy-preserving validation of spatial correlations between environmental exposures and disease-associated gene expression, without revealing raw location. The claim is that effect estimates computed over ZKP-verified-but-location-hidden records fall within 10% relative error of the same analysis on disclosed coordinates. Amended 24 August 2026. As published this was worked through CTSS/DNMT1/ZNF740 expression as the example disease signal. Those targets did not replicate (CTSS non-significant; ZNF740 and DNMT1 sign-reversed in the independent GSE138614 cohort), so the example is withdrawn. It is deliberately not replaced with another named gene set: the cryptographic claim is gene-agnostic, and substituting a different target would imply a biological test that has not been run.
Zero-knowledge proofs of geospatial provenance assertions (e.g. "this record originated within 10 km of a named clinical trial site") can be integrated with federated transcriptomic datasets to enable privacy-preserving validation of spatial correlations between environmental exposures and disease-associated gene expression, without revealing raw location. The claim is that effect estimates computed over ZKP-verified-but-location-hidden records fall within 10% relative error of the same analysis on disclosed coordinates.
Amended 24 August 2026. As published this was worked through CTSS/DNMT1/ZNF740 expression as the example disease signal. Those targets did not replicate (CTSS non-significant; ZNF740 and DNMT1 sign-reversed in the independent GSE138614 cohort), so the example is withdrawn. It is deliberately not replaced with another named gene set: the cryptographic claim is gene-agnostic, and substituting a different target would imply a biological test that has not been run.
Adversarial Debate Score
65% survival rate under critique
Expert panel critique
Independent views, each critiquing the hypothesis on its own — the score rewards genuine disagreement and discounts consensus.
Supporting Research Papers
- RAFT-UP: Robust Alignment for Spatial Transcriptomics with Explicit Control of Spatial Distortion
Spatial transcriptomics (ST) profiles gene expression across a tissue section while preserving the spatial coordinates. Because current ST technologies typically profile two-dimensional tissue slices,...
- M³-Gen: Interpretable Multimodal Generation of Gene Expression Profiles Using Clinical and Imaging Data
Integrating heterogeneous biomedical data, including clinical metadata, histopathology images, and molecular profiles, is crucial for comprehensive disease understanding. However, gene expression data...
- SNPgen: Phenotype-Supervised Genotype Representation and Synthetic Data Generation via Latent Diffusion
Polygenic risk scores and other genomic analyses require large individual-level genotype datasets, yet strict data access restrictions impede sharing. Synthetic genotype generation offers a privacy-pr...
- Quantifying Memorization and Privacy Risks in Genomic Language Models
Genomic language models (GLMs) have emerged as powerful tools for learning representations of DNA sequences, enabling advances in variant prediction, regulatory element identification, and cross-task ...
- TRACE-CTI: Auditable Post-Extraction Governance of TTP Claims with Knowledge Graphs
Security Operations Centers increasingly rely on automated mapping of Cyber Threat Intelligence reports to MITRE ATT&CK, yet extractor outputs remain fallible and are often stored without the evidence...
Literature Assessment
An LLM's reading of the literature — not computational verification.
Integration of zero-knowledge proofs with transcriptomic data is plausible but faces significant challenges.
Method: literature_meta · Result: inconclusive
Formal Verification
Z3 checks whether the hypothesis is internally consistent, not whether it is empirically true.
This discovery has a Claude-generated validation package with a full experimental design.
Precise Hypothesis
A zero-knowledge proof (ZKP) protocol can attest that a biospecimen/metadata record originated within a bounded geographic region (e.g., "within 10km of clinical trial site X" or "within an EPA-defined pollution exposure zone") — verifiable by a third party with cryptographic soundness ≥99.99% (false-accept rate) and completeness ≥99% — while the verifier learns nothing about the exact coordinates beyond membership in the disclosed region (statistical distinguishability advantage <0.01 between true and simulated proof transcripts).
- Proof soundness failure: an adversarial prover can construct a valid ZKP for a false location claim with probability >10^-4 across 10,000 adversarial trials. 2. Privacy leakage: a verifier or colluding third party can reconstruct the true coordinates (or narrow to <10km precision beyond the stated region) with >5% success rate above baseline guessing, measured via a distinguishing/membership-inference attack. 3. Statistical distortion: the ZKP-gated correlation coefficient (region-hidden) deviates from the raw-coordinate correlation by >10% relative error, or changes significance at α=0.05 in >1/20 bootstrap resamples. 4. Non-scalability: circuit compilation + proof generation exceeds 60 seconds per record on commodity hardware (16-core CPU, no GPU) at n=10,000 records, making federated deployment impractical. 5.
Spine & Adversarial ReadReady for validation
“This hypothesis tests whether a zero-knowledge proof of geospatial region membership can replace raw coordinate disclosure in a federated transcriptomic analysis without changing the statistical conclusion of a spatial gene-expression correlation by more than 10%.”
- high
- highWhy zero-knowledge proofs specifically, rather than simpler, cheaper privacy techniques (differential privacy on coordinates, k-anonymity spatial cloaking, secure multi-party computation, or trusted execution environments) that are already well-established in federated health data literature? The methodology justification for ZKPs over these alternatives is not stated.Gap acknowledged, not resolved. ZKPs offer a unique property (cryptographic soundness of a *provenance claim* — proving the location predicate is true — rather than merely obscuring it), which DP/k-anonymity do not provide since they don't verify the claim's truthfulness. This distinction (verification vs. obfuscation) should be made an explicit comparison arm in the protocol (Step 3.5, not currently included): benchmark ZKP against DP-noised coordinates and secure-aggregation MPC on the same synthetic dataset to demonstrate the utility/privacy/verifiability tradeoff empirically rather than asserting ZKP superiority a priori.
- mediumThe statistical fidelity target (relative error <10%) is compared only against a synthetic ground truth with a single injected effect size (r=0.3);Not resolved — the protocol should add a power-analysis sub-study varying injected effect size (r = 0.1 to 0.5) and region granularity to map the actual usable operating range before claiming general success, since a single r=0.3 synthetic benchmark is insufficiently conservative for a modest real-world effect.
Experimental Protocol
Minimum Viable Test (MVT): A two-arm synthetic-data benchmark. - Arm B (ZK-gated): Same records, but location replaced by a ZKP attestation of "within region R_i" for 20 predefined regions; raw coordinates withheld from the analysis engine. - Separately run cryptographic benchmarks: proof generation time, verification time, proof size, soundness/completeness under fuzzing (10,000 malicious proof attempts with off-region coordinates).
- GSE193770, GSE108000, GSE138614 (real transcriptomic data, for effect-size calibration only — these datasets do NOT contain real patient geolocation and cannot be used for the spatial-privacy test directly; a synthetic geo-layer must be grafted on). - A ZKP framework/toolkit: circom + snarkjs (Groth16), or Halo2 (no trusted setup), or gnark (Go, fast prover).
- Soundness: false-accept rate <10^-4 over 10,000 adversarial trials. - Privacy: membership-inference/reconstruction AUC ≤0.55 (near-chance) against the ZK-gated pipeline. - Statistical fidelity: relative error between Arm A and Arm B correlation/regression coefficients <10%; p-value significance calls concordant in ≥95% of bootstrap resamples. - Performance: proof generation <5s/record, verification <100ms/record, total pipeline overhead <2x the raw-coordinate pipeline at N=10,000. - Federation robustness: results stable (coefficient drift <15%) across 3–5 simulated heterogeneous sites with dropout up to 20%.
- Any soundness failure rate >10^-3 in adversarial testing → cryptographic disproof. - Reconstruction AUC >0.65 → privacy disproof. - Relative statistical error >20% or discordant significance calls in >10% of resamples → statistical-utility disproof. - Proof generation time >60s/record at N=10,000 (impractical for registry-scale deployment) → scalability disproof. site-internal raw analysis → use-case disproof (biological, not cryptographic).
ROI Projection
- Direct: licensable privacy-infrastructure IP (ZK circuit library for geospatial health-data predicates) applicable beyond MS to any exposure-disease research (cancer clusters, environmental toxicology, infectious disease). - Platform value: could underpin a federated-research-as-a-service product for pharma/CRO multi-site trials requiring geographic eligibility verification (e.g., "within 10km of trial site") without PHI exposure — addressable market includes clinical trial recruitment compliance tooling (est. $50–150M niche market). - Regulatory value: potential fast-track alignment with GDPR/HIPAA "privacy by design" mandates, reducing legal/compliance overhead for multi-national MS consortia (e.g., MSBase, iConquerMS). TIME_TO_RESULT_DAYS: 60 (For the minimum viable synthetic-only cryptographic + statistical fidelity benchmark. Full validation including real-site pilot and audit: ~365 days.)